chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Loss of consciousness, Nausea, Vaccination complication, Vomiting
Clinical narrative: passed out; had quite a reaction to the booster; nauseous; vomited; had a very intense headache; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 011A21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache). At the time of the report, LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) outcome was unknown.            She says that she had quite a reaction to the booster. Patient stated that about 15 hours after the 2nd dose & booster dose patient was nauseous, vomited, passed out, & had a very intense headache.  Concomitant products were not provided.  Treatment medication were not reported.   This case was linked to MOD-2021-406073 (Patient Link).
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: Rash appearing on trunk,arms,legs,intermittant throughout the day; Redness itiching with hives on her neck trunk; Redness itiching with hives on her neck trunk; Redness itiching with hives on her neck trunk; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness itiching with hives on her neck trunk), PRURITUS (Redness itiching with hives on her neck trunk), URTICARIA (Redness itiching with hives on her neck trunk) and RASH (Rash appearing on trunk,arms,legs,intermittant throughout the day) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced ERYTHEMA (Redness itiching with hives on her neck trunk), PRURITUS (Redness itiching with hives on her neck trunk) and URTICARIA (Redness itiching with hives on her neck trunk). On 13-Dec-2021, the patient experienced RASH (Rash appearing on trunk,arms,legs,intermittant throughout the day). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Redness itiching with hives on her neck trunk), PRURITUS (Redness itiching with hives on her neck trunk), URTICARIA (Redness itiching with hives on her neck trunk) and RASH (Rash appearing on trunk,arms,legs,intermittant throughout the day) had not resolved.            No relevant concomitant medications were provided. No treatment information was provided. Patient continued to experience symptoms and had no resolution at the time of reporting.   This case was linked to MOD-2021-406383, MOD-2021-410574 (Patient Link).
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pain, Pain in extremity, Pyrexia
Clinical narrative: Like mild flu symptoms after 2nd shot; Achiness after 2nd shot; Sore left arm after 2nd shot; Low fever 99F after 2nd shot; Chills after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Like mild flu symptoms after 2nd shot), PAIN (Achiness after 2nd shot), PAIN IN EXTREMITY (Sore left arm after 2nd shot), PYREXIA (Low fever 99F after 2nd shot) and CHILLS (Chills after 2nd shot) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Like mild flu symptoms after 2nd shot), PAIN (Achiness after 2nd shot), PAIN IN EXTREMITY (Sore left arm after 2nd shot), PYREXIA (Low fever 99F after 2nd shot) and CHILLS (Chills after 2nd shot). On 29-Jan-2021, INFLUENZA LIKE ILLNESS (Like mild flu symptoms after 2nd shot), PAIN (Achiness after 2nd shot), PAIN IN EXTREMITY (Sore left arm after 2nd shot), PYREXIA (Low fever 99F after 2nd shot) and CHILLS (Chills after 2nd shot) had resolved.            Concomitant product use was not provided by the reporter.  Treatment medication was not provided by the reporter.  Patient's symptoms was lasted for 3 days.   This case was linked to MOD-2021-410964, MOD-2021-410984 (Patient Link).
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Dysuria, Urinary tract infection
Clinical narrative: Pain when urinated; Blood in urine; Urinary bladder infection; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Pain when urinated), BLOOD URINE PRESENT (Blood in urine) and URINARY TRACT INFECTION (Urinary bladder infection) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSURIA (Pain when urinated), BLOOD URINE PRESENT (Blood in urine) and URINARY TRACT INFECTION (Urinary bladder infection). At the time of the report, DYSURIA (Pain when urinated), BLOOD URINE PRESENT (Blood in urine) and URINARY TRACT INFECTION (Urinary bladder infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood urine present: positive (Positive) Positive.         Patient had 2 fundamental shots back in February. No concomitant medication details was reported. Treatment medications taken Twice a day, 11 hours apart with name unspecified.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 026C21A) for COVID-19 vaccination.     Concomitant products included TRIAMCINOLONE ACETONIDE from 25-Oct-2021 to an unknown date, MUPIROCIN from 25-Oct-2021 to an unknown date and IBUPROFEN from 25-Oct-2021 to 25-Oct-2021 for an unknown indication.   On 25-Oct-2021 at 4:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Nov-2021 at 10:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Nov-2021 at 10:15 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 27-Nov-2021 at 10:15 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history information was reported. The patient got administered  a 2nd dose from a different vial with the same lot number on 27 Nov 2021. The Moderna vial was moved from freezer to refrigerator on 27 Nov 2021, the same day the dose was administered.  No treatment medication was provided.   This case was linked to MOD-2021-413201 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Pruritus, Rash pruritic, Swelling
Clinical narrative: menstruation problems/With the menstruation the problems appeared after 15 day from the second dose; it itches on the body; like red spots; swollen/sometimes it goes and sometimes it comes; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (menstruation problems/With the menstruation the problems appeared after 15 day from the second dose), PRURITUS (it itches on the body), RASH PRURITIC (like red spots) and SWELLING (swollen/sometimes it goes and sometimes it comes) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced MENSTRUAL DISORDER (menstruation problems/With the menstruation the problems appeared after 15 day from the second dose). 2021, the patient experienced PRURITUS (it itches on the body), RASH PRURITIC (like red spots) and SWELLING (swollen/sometimes it goes and sometimes it comes). At the time of the report, MENSTRUAL DISORDER (menstruation problems/With the menstruation the problems appeared after 15 day from the second dose), PRURITUS (it itches on the body), RASH PRURITIC (like red spots) and SWELLING (swollen/sometimes it goes and sometimes it comes) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported. Reporter stated the village where I live a lot of people is suffering this.   This case was linked to MOD-2021-413613, MOD-2021-413614, MOD-2021-413615 (Patient Link).
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: After the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (After the expiration date) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (After the expiration date). On 21-Sep-2021, EXPIRED PRODUCT ADMINISTERED (After the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications and treatment information were not provided by reporter.  Reporter reported that none of the patients experienced any reported symptoms and no treatments or additional doses have been provided.   This case was linked to MOD-2021-413581, MOD-2021-413535 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after the vaccine had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired). On 21-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medications was reported. Reporter reported that none of the patients experienced any reported symptoms.   This case was linked to MOD-2021-413581, MOD-2021-413560, MOD-2021-413545, MOD-2021-413568, MOD-2021-413587, MOD-2021-413590, MOD-2021-413591, MOD-2021-413593, MOD-2021-413594, MOD-2021-413597, MOD-2021-413598, MOD-2021-413599, MOD-2021-413600, MOD-2021-413434 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after the vaccine had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired). On 21-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided. Reporter reported that None of the patients experienced any reported symptoms.   This case was linked to MOD-2021-413535, MOD-2021-413554 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: After the expiration date; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (After the expiration date) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (After the expiration date). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (After the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported. Patient have no reported symptoms.   This case was linked to MOD-2021-413535, MOD-2021-413545, MOD-2021-413560, MOD-2021-413568, MOD-2021-413581, MOD-2021-413587, MOD-2021-413590, MOD-2021-413593, MOD-2021-413591, MOD-2021-413594, MOD-2021-413597, MOD-2021-413598, MOD-2021-413599, MOD-2021-413600 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered after the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered after the expiration date) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered after the expiration date). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered after the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications  were reported. No treatment information was provided Reporter stated that none of the patients experienced any reported symptoms and no treatments or additional doses have been provided.   This case was linked to MOD-2021-413535, MOD-2021-413554, MOD-2021-413434, MOD-2021-413560, MOD-2021-413600, MOD-2021-413598, MOD-2021-413599, MOD-2021-413597, MOD-2021-413594, MOD-2021-413593, MOD-2021-413591, MOD-2021-413590, MOD-2021-413587, MOD-2021-413581, MOD-2021-413568, MOD-2021-413560 (Patient Link).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: His clinic had administered 16 doses of the Moderna covid-19 vaccine by intramuscular injection between 21SEP2021 and 23SEP2021 after the vaccine had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (His clinic had administered 16 doses of the Moderna covid-19 vaccine by intramuscular injection between 21SEP2021 and 23SEP2021 after the vaccine had expired) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (His clinic had administered 16 doses of the Moderna covid-19 vaccine by intramuscular injection between 21SEP2021 and 23SEP2021 after the vaccine had expired). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (His clinic had administered 16 doses of the Moderna covid-19 vaccine by intramuscular injection between 21SEP2021 and 23SEP2021 after the vaccine had expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. No adverse events were reported.   This case was linked to MOD-2021-413535, MOD-2021-413554 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Knot in the arm of the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Knot in the arm of the vaccination) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Knot in the arm of the vaccination). At the time of the report, VACCINATION SITE MASS (Knot in the arm of the vaccination) had not resolved.            No Concomitant product use was reported. No treatment information was provided.  The reporter got the booster on 13-Dec-2021 and at the time of the call, on 15-Dec-2021 the patient was still feeling a knot on their right arm where the dose was administered.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep deficit, Vomiting
Clinical narrative: Last night she was up all night vomiting; Last night she was up all night vomiting; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DEFICIT (Last night she was up all night vomiting) and VOMITING (Last night she was up all night vomiting) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Dec-2021, the patient experienced SLEEP DEFICIT (Last night she was up all night vomiting). 14-Dec-2021, the patient experienced VOMITING (Last night she was up all night vomiting). At the time of the report, SLEEP DEFICIT (Last night she was up all night vomiting) and VOMITING (Last night she was up all night vomiting) outcome was unknown. No Concomitant product use was reported. No treatment information was provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Induration, Pain, Pruritus, Swelling
Clinical narrative: the area had been itching; pain; swelling; hardness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), INDURATION (hardness), PRURITUS (the area had been itching) and PAIN (pain) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A, 016B21A and 045(or S)J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), INDURATION (hardness), PRURITUS (the area had been itching) and PAIN (pain). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWELLING (swelling), INDURATION (hardness) and PAIN (pain) had resolved and PRURITUS (the area had been itching) outcome was unknown.            No concomitant medications provided. Treatment included ice, pain medications and observing.
Sex: M
Vaccine: COVID19
Symptoms: Skin odour abnormal
Clinical narrative: smells like a "putrid odor" because he has been vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of SKIN ODOUR ABNORMAL (smells like a "putrid odor" because he has been vaccinated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN ODOUR ABNORMAL (smells like a "putrid odor" because he has been vaccinated). At the time of the report, SKIN ODOUR ABNORMAL (smells like a "putrid odor" because he has been vaccinated) outcome was unknown.            Concomitant medications was not reported.  Treatment medications was not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: After 2nd dose had a rash minor rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (After 2nd dose had a rash minor rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chronic disease (Chronic illness).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (After 2nd dose had a rash minor rash). At the time of the report, RASH (After 2nd dose had a rash minor rash) outcome was unknown.            No concomitant medications were mentioned. No treatment details were reported.   This case was linked to MOD-2021-413761 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Feeling abnormal, Illness, Rash
Clinical narrative: the booster shot is weakening her system; has anxiety; not feeling well; coming from somewhere what's making her sick; after the booster was suffering a horrendous rash/the rash was very uncomfortable to work/rash was been there for almost 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (the booster shot is weakening her system), ANXIETY (has anxiety), FEELING ABNORMAL (not feeling well), ILLNESS (coming from somewhere what's making her sick) and RASH (after the booster was suffering a horrendous rash/the rash was very uncomfortable to work/rash was been there for almost 3 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (the booster shot is weakening her system), ANXIETY (has anxiety), FEELING ABNORMAL (not feeling well), ILLNESS (coming from somewhere what's making her sick) and RASH (after the booster was suffering a horrendous rash/the rash was very uncomfortable to work/rash was been there for almost 3 days). At the time of the report, ASTHENIA (the booster shot is weakening her system), ANXIETY (has anxiety), FEELING ABNORMAL (not feeling well) and ILLNESS (coming from somewhere what's making her sick) outcome was unknown and RASH (after the booster was suffering a horrendous rash/the rash was very uncomfortable to work/rash was been there for almost 3 days) had not resolved.            No concomitant medication was reported.  No treatment medication use was reported.   This case was linked to MOD-2021-413742 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain in extremity
Clinical narrative: headache/Since the 2nd dose, it seems like I have a recurrent headache; I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips; It started with knees, then soon after it was my ankles, now wrists, hands, & hips; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (My oxygen reached 20%. I was in the hospital from 05Jan2021 through 13 JAN 2021) in January 2020 and Limb hyperextension.    On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips). The patient was treated with PARACETAMOL (NON ASPIRIN) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   There's a PKD (Polycystic kidney disease) History in family, but the patient remain negative. Concomitant medications were not reported. On 15-May-2021, the patient had a headache, tremendous breakdown and pain in all of my joints. Both knees at same time went bad. All of my joints are in tremendous pain. It started with knees, then soon after it was my ankles, now wrists, hands, & hips. Since the 2nd dose, it seems like I have a recurrent headache.  The took non aspirin regularly.   This case was linked to MOD-2021-413812 (Patient Link).
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pityriasis rosea, Pyrexia
Clinical narrative: The patient had a herald patch which was a precursor to developing Pityriasis Rosea; fever; chills; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea), PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H2A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pfizer (2nd dose) and pfizer (1st dose). Past adverse reactions to the above products included No adverse reaction with pfizer and pfizer.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches). On 30-Nov-2021, the patient experienced PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. On 24-Nov-2021, PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches) had resolved. At the time of the report, PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea) had not resolved.            Concomitant medications were not reported.  Patient noticed dry patches on back and patches had gotten bigger. On 13-DEC-2021, he went to dermatologist. The doctor indicated that he had a herald patch which was a precursor to developing Pityriasis Rosea. It was look like he was in between stages and once he had Pityriasis Rosea it could last 2 to 6 months before clearing.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: really dizzy and felt like she could pass out; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (really dizzy and felt like she could pass out) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 023M20A and 013L20B) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (really dizzy and felt like she could pass out). At the time of the report, DIZZINESS (really dizzy and felt like she could pass out) outcome was unknown.            Patient is on Blood pressure medication.  The patient thought this is due to the low blood pressure condition that landed in the hospital.   First dose of the suspect product was administered on 27Jan2021 with batch number 013L20B Second dose of the suspect product was administered on 24Jan2021 with batch number 023M20A  No Treatment information was provided.   This case was linked to MOD-2021-413683 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia, Vaccination site reaction
Clinical narrative: Covid arm; Fever; Severe body aches; Joint aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), PYREXIA (Fever), MYALGIA (Severe body aches) and ARTHRALGIA (Joint aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm), PYREXIA (Fever), MYALGIA (Severe body aches) and ARTHRALGIA (Joint aches). At the time of the report, VACCINATION SITE REACTION (Covid arm), PYREXIA (Fever), MYALGIA (Severe body aches) and ARTHRALGIA (Joint aches) outcome was unknown.            No relevant concomitant medications were provided.  No treatment information was provided.   This case was linked to MOD-2021-409912 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Food allergy
Clinical narrative: diagnose with alpha-GAL syndrome after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FOOD ALLERGY (diagnose with alpha-GAL syndrome after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FOOD ALLERGY (diagnose with alpha-GAL syndrome after vaccination). At the time of the report, FOOD ALLERGY (diagnose with alpha-GAL syndrome after vaccination) outcome was unknown.            No concomitant medications were reported Patient was wondererd about the origins of the cholesterol in the ingredients. No treatment medications were reported
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: The administration would have been approximately 18 hours post puncture; 1st dose of Janssen and Booster dose of Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The administration would have been approximately 18 hours post puncture) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Janssen and Booster dose of Moderna) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Janssen (Patient received 1st dose of Janssen.). Past adverse reactions to the above products included No adverse event with Janssen.    On 14-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The administration would have been approximately 18 hours post puncture) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Janssen and Booster dose of Moderna). On 14-Dec-2021, EXPIRED PRODUCT ADMINISTERED (The administration would have been approximately 18 hours post puncture) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Janssen and Booster dose of Moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-414566, MOD-2021-414591 (Patient Link).
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired Vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 026C21A) for COVID-19 vaccination.     Concomitant products included TRIAMCINOLONE ACETONIDE from 25-Oct-2021 to an unknown date, MUPIROCIN from 25-Oct-2021 to an unknown date and IBUPROFEN from 25-Oct-2021 to 25-Oct-2021 for an unknown indication.   On 25-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). On 27-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.    This case was linked to MOD-2021-400101 (Patient Link).
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pruritus, Rash, Skin reaction
Clinical narrative: low energy (mild); itching (mild); Skin reaction (mild); rash all over the body (mild); headaches (mild); This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (low energy (mild)), PRURITUS (itching (mild)), SKIN REACTION (Skin reaction (mild)), RASH (rash all over the body (mild)) and HEADACHE (headaches (mild)) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.    In October 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2021, the patient experienced ASTHENIA (low energy (mild)), PRURITUS (itching (mild)), SKIN REACTION (Skin reaction (mild)), RASH (rash all over the body (mild)) and HEADACHE (headaches (mild)). The patient was treated with CYPROHEPTADINE for Itching, at an unspecified dose and frequency. At the time of the report, ASTHENIA (low energy (mild)), PRURITUS (itching (mild)), SKIN REACTION (Skin reaction (mild)), RASH (rash all over the body (mild)) and HEADACHE (headaches (mild)) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history was provided by the reporter.   This case was linked to MOD-2021-414672 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itch on his back and arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch on his back and arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced PRURITUS (itch on his back and arm). At the time of the report, PRURITUS (itch on his back and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Nurse stated the dose was administered 12  hours after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nurse stated the dose was administered 12  hours after expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021 at 10:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021 at 10:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Nurse stated the dose was administered 12  hours after expiration date). On 15-Dec-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (Nurse stated the dose was administered 12  hours after expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Antibody test, Eczema, Eczema eyelids, Inappropriate schedule of product administration
Clinical narrative: hair loss; incredibly itchy; experiencing eczema on scalp,face,forehead and neck; rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back; 1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021; after 2nd dose it became full blown eczema; I've had it on eyelids; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (after 2nd dose it became full blown eczema), ECZEMA EYELIDS (I've had it on eyelids), ALOPECIA (hair loss), RASH PRURITIC (incredibly itchy) and ECZEMA (experiencing eczema on scalp,face,forehead and neck) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Asthma. Concomitant products included MOMETASONE FUROATE (NASONEX) for Allergy, LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) for Asthma.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ECZEMA (after 2nd dose it became full blown eczema), ECZEMA EYELIDS (I've had it on eyelids), RASH PRURITIC (incredibly itchy), ECZEMA (experiencing eczema on scalp,face,forehead and neck), ECZEMA (rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021). On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ECZEMA (after 2nd dose it became full blown eczema) and ECZEMA (experiencing eczema on scalp,face,forehead and neck) had not resolved, ECZEMA EYELIDS (I've had it on eyelids), ALOPECIA (hair loss), RASH PRURITIC (incredibly itchy) and ECZEMA (rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back) was resolving and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antibody test: other (High) high level of antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was prescribed 3 or 4 topical ointments by her dermatologist but nothing seemed to help.   This case was linked to MOD-2021-414585 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: hair loss; incredibly itchy; experiencing eczema on scalp,face,forehead and neck; rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back; 1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021; after 2nd dose it became full blown eczema; I've had it on eyelids; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (after 2nd dose it became full blown eczema), ECZEMA EYELIDS (I've had it on eyelids), ALOPECIA (hair loss), RASH PRURITIC (incredibly itchy) and ECZEMA (experiencing eczema on scalp,face,forehead and neck) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Asthma. Concomitant products included MOMETASONE FUROATE (NASONEX) for Allergy, LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) for Asthma.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ECZEMA (after 2nd dose it became full blown eczema), ECZEMA EYELIDS (I've had it on eyelids), RASH PRURITIC (incredibly itchy), ECZEMA (experiencing eczema on scalp,face,forehead and neck), ECZEMA (rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021). On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ECZEMA (after 2nd dose it became full blown eczema) and ECZEMA (experiencing eczema on scalp,face,forehead and neck) had not resolved, ECZEMA EYELIDS (I've had it on eyelids), ALOPECIA (hair loss), RASH PRURITIC (incredibly itchy) and ECZEMA (rashes from the eczema would come and go and move. She has had it on the back of her knees, belly button, top to thighs, and all over her back) was resolving and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna COVID-19 vaccine on 29JAN2021 Expiration date for lot # is unknown) and the second dose on 3MAR2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antibody test: other (High) high level of antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was prescribed 3 or 4 topical ointments by her dermatologist but nothing seemed to help.   This case was linked to MOD-2021-414585 (Patient Link).